Oxazolidinone cotherapy
OwnerJoseph Patrick Martin JR., Michael J. Dupuis +1inventors
InventorsJoseph Patrick Martin JR., Michael J. Dupuis, John T. Herberg
Life of this patent
Estimating the term…
Abstract
The present invention describes a novel cotherapy of oxazolidinones and at least one vitamin selected from vitamin B2, vitamin B6, vitamin B12 and folic acid.
Claims69
A method of treating a patient in need of oxazolidinone by administering an effective amount of oxazolidinone and an effective amount of at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid.
A method of treating or preventing an oxazolidinone-associated side effect by administering an effective amount at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated normocytic anemia by administering an effective amount of vitamin B2 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated peripheral sensory neuropathy by administering an effective amount of vitamin B2 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated sideroblastic anemia by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated peripheral sensory neuropathy by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated optic neuropathy by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated seizures by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated thrombocytopenia by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated cheilosis by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated seborrheic dermatitis by administering an effective amount of vitamin B6 to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated hyporegenerative anemia by administering an effective amount at least one vitamin selected from the group consisting of vitamin B12 and folic acid to a patient in need thereof.
A method of treating or preventing oxazolidinone-associated megaloblastic anemia by administering an effective amount at least one vitamin selected from the group consisting of vitamin B12 and folic acid to a patient in need thereof.
A method of treating or preventing a bacterial infection by administering an effective amount of oxazolidinone and an effective amount of at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid.
A method of treating or preventing a depressive disorder by administering an effective amount of oxazolidinone and an effective amount of at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid.
A pharmaceutical composition comprising (a) oxazolidinone and (b) at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid.
A medical kit comprising (a) oxazolidinone and (b) at least one vitamin selected from the group consisting of vitamin B2, vitamin B6, vitamin B12 and folic acid.
Dependencies are inferred from the claim text.